Flutamide for prostate cancer.
D000813:Anilides / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005485:Flutamide / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D016729:Leuprolide; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000813:Anilides; D007987:Gonadotropin-Releasing Hormone; D005485:Flutamide; D016729:Leuprolide